New bid for Allergan not even close, board tells suitor Valeant

Posted: June 11, 2014 at 2:45 a.m.

Allergan's board has unanimously rejected the latest takeover bid from Valeant Pharmaceuticals, and the Botox maker said the offer isn't even worth talking about.

This story is only available from our archives.


« Previous Story

United joins Delta in shift to fare-based loy...

United Continental Holdings Inc.'s move to base frequent-flier rewards on fares instead of distance flown is seen as likely to force American Airlines Group Inc. and foreig... Read »

Next Story »

U.S. job postings jumped in April

A job seeker (left) talks to a sales manager with Trillium Staffing at a job fair last month in Muskegon, Mich. Job openings in the U.S. climbed in April, the Labor Department said Tuesday.

Job openings in the U.S. climbed to an almost seven-year high in April as employers sought more workers to he... Read »